Clinical Trial Update: Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating intermittent androgen deprivation therapy with or without stereotactic body radiotherapy for hormone-sensitive oligometastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING